(Q33946887)

30 July 2017

1 reference

title

Management of the adverse effects of antiretroviral therapy and medication adherence (English)

1 reference

30 July 2017

main subject

anti-retroviral agent

0 references

author name string

Max B

series ordinal

1

1 reference

30 July 2017

Sherer R

series ordinal

2

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 June 2000

1 reference

Clinical Infectious Diseases

30 July 2017

published in

1 reference

30 July 2017

volume

30 Suppl 2

1 reference

30 July 2017

page(s)

S96-116

1 reference

Marked declines in human immunodeficiency virus-related mortality in Chicago in women, African Americans, Hispanics, young adults, and injection drug users, from 1995 through 1997.

30 July 2017

cites work

1 reference

Comparison of mitochondrial morphology, mitochondrial DNA content, and cell viability in cultured cells treated with three anti-human immunodeficiency virus dideoxynucleosides

21 January 2018

1 reference

Zidovudine-induced fatal lactic acidosis and hepatic failure in patients with acquired immunodeficiency syndrome: report of two patients and review of the literature

21 January 2018

1 reference

Lactic acidosis associated with stavudine administration: a report of five cases

21 January 2018

1 reference

Mitochondrial toxicity of antiviral drugs

21 January 2018

1 reference

Pharmacokinetics of zidovudine in patients with liver cirrhosis

21 January 2018

1 reference

The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial

21 January 2018

1 reference

Zidovudine in asymptomatic human immunodeficiency virus infection. A controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter. The AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases

21 January 2018

1 reference

Changing etiology of macrocytosis. Zidovudine as a frequent causative factor

21 January 2018

1 reference

Prognosis in AZT myopathy

21 January 2018

1 reference

Hyperosmolar nonketotic diabetic syndrome following treatment of human immunodeficiency virus infection with didanosine

21 January 2018

1 reference

Safety and tolerance of dideoxycytidine as a single agent. Results of early-phase studies in patients with acquired immunodeficiency syndrome (AIDS) or advanced AIDS-related complex. Study Group of the AIDS Clinical Trials Group of the National Inst

21 January 2018

1 reference

A comparative trial of didanosine or zalcitabine after treatment with zidovudine in patients with human immunodeficiency virus infection. The Terry Beirn Community Programs for Clinical Research on AIDS.

21 January 2018

1 reference

Dermatologic complications associated with administration of 2',3'-dideoxycytidine in patients with human immunodeficiency virus infection

21 January 2018

1 reference

Stavudine in patients with AIDS and AIDS-related complex: AIDS clinical trials group 089.

21 January 2018

1 reference

Clinical efficacy of monotherapy with stavudine compared with zidovudine in HIV-infected, zidovudine-experienced patients. A randomized, double-blind, controlled trial. Bristol-Myers Squibb Stavudine/019 Study Group

21 January 2018

1 reference

The didanosine Expanded Access Program: safety analysis

21 January 2018

1 reference

Efficacy of desipramine in painful diabetic neuropathy: a placebo-controlled trial

21 January 2018

1 reference

Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial.

21 January 2018

1 reference

Mexiletine for HIV-infected patients with painful peripheral neuropathy: a double-blind, placebo-controlled, crossover treatment trial

21 January 2018

1 reference

Effects of (-)-2'-deoxy-3'-thiacytidine (3TC) 5'-triphosphate on human immunodeficiency virus reverse transcriptase and mammalian DNA polymerases alpha, beta, and gamma

21 January 2018

1 reference

A one-year trial of lamivudine for chronic hepatitis B. Asia Hepatitis Lamivudine Study Group.

21 January 2018

1 reference

Locations of anti-AIDS drug binding sites and resistance mutations in the three-dimensional structure of HIV-1 reverse transcriptase. Implications for mechanisms of drug inhibition and resistance

21 January 2018

1 reference

A randomized, double-blind trial comparing combinations of nevirapine, didanosine, and zidovudine for HIV-infected patients: the INCAS Trial. Italy, The Netherlands, Canada and Australia Study

21 January 2018

1 reference

Evidence for a single genetic locus in Clouston's hidrotic ectodermal dysplasia.

21 January 2018

1 reference

21 January 2018

HIV-protease inhibitors

1 reference

Toward HIV eradication or remission: the tasks ahead

21 January 2018

1 reference

Combination therapy containing ritonavir plus saquinavir has superior short-term antiretroviral efficacy: a randomized trial.

21 January 2018

1 reference

Severe hyperglycemia in an HIV clinic: preexisting versus drug-associated diabetes mellitus

21 January 2018

1 reference

Indinavir-associated lipodystrophy.

21 January 2018

1 reference

"Buffalo hump" in men with HIV-1 infection.

21 January 2018

1 reference

HIV protease inhibitor-related lipodystrophy syndrome

21 January 2018

1 reference

Inhibitory effect of 9-(2-phosphonylmethoxyethyl)-adenine (PMEA) on human and duck hepatitis B virus infection

21 January 2018

1 reference

Treat HIV-1 infection like other infections--treat it.

21 January 2018

1 reference

The case for conservative management of early HIV disease.

21 January 2018

1 reference

HIV/AIDS in 1998--gaining the upper hand?

21 January 2018

1 reference

Antiretroviral drug resistance testing in adults with HIV infection: implications for clinical management. International AIDS Society--USA Panel.

21 January 2018

1 reference

HIV treatment failure: testing for HIV resistance in clinical practice

21 January 2018

1 reference

Drug-resistance genotyping in HIV-1 therapy: the VIRADAPT randomised controlled trial.

21 January 2018

1 reference

Anaphylaxis after rechallenge with abacavir

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1086/313859

1 reference

30 July 2017

1 reference